Name: Opus Genetics, Inc. (IRD) Balance Sheet
Creator: FinSpry

Opus Genetics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Opus Genetics, Inc. (IRD) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	30.32	50.50	42.63	24.53	16.40
Short-Term Investments	0.00	0.02	0.05	0.22	0.00
Cash & Short-Term Investments	30.32	50.52	42.68	24.75	16.40
Accounts Receivable	5.77	0.93	1.30	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.52	1.10	0.08	0.07	1.24
Total Current Assets	36.61	53.95	48.99	26.07	17.67
Non-Current Assets
Property, Plant & Equipment (Net)	0.25	0.00	0.01	0.01	0.01
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.25	0.00	0.01	0.01	0.00
Total Assets	36.86	53.95	48.99	26.08	17.68
Current Liabilities
Accounts Payable	3.15	2.15	1.07	1.58	1.21
Short-Term Debt	0.00	0.00	0.00	0.54	0.00
Accrued Liabilities	8.15	1.82	1.37	1.73	1.97
Other Current Liabilities	0.00	0.07	0.00	0.00	0.00
Total Current Liabilities	11.30	4.04	2.75	3.86	3.19
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	18.84	0.00	0.00	0.00	27.96
Total Non-Current Liabilities	18.84	0.00	0.00	0.00	0.00
Total Liabilities	11.30	4.04	2.75	3.86	31.15
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-139.00	-81.47	-71.48	-89.37	-32.68
Additional Paid-in Capital	145.72	131.37	117.72	111.59	0.00
Shares Outstanding	31.57	23.98	20.86	18.85	0.00
Total Stockholders' Equity	25.57	49.91	46.24	22.22	-13.47
Total Liabilities & Equity	36.86	53.95	48.99	26.08	0.00